What does Tenaya Therapeutics, Inc. do?
Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in Phase 1b/2 clinical trial;…
What is Tenaya Therapeutics, Inc.'s P/E and P/B ratio?
Tenaya Therapeutics, Inc. has a P/E ratio of -0.7 and a P/B ratio of 1.25.
What is Tenaya Therapeutics, Inc.'s debt-to-equity ratio?
Tenaya Therapeutics, Inc. has a debt-to-equity ratio of 0.06.
How much does Tenaya Therapeutics, Inc. owe compared with what it owns?
Tenaya Therapeutics, Inc. owes $0.26 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Tenaya Therapeutics, Inc.'s Positivity rank?
Tenaya Therapeutics, Inc. is ranked #3,600 of 6,774 companies globally and #1,585 of 4,000 in United States on PositoAI, with a Positivity Score of 20,420.
Does Tenaya Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Yes. Tenaya Therapeutics, Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 30 Jan 2026). It has no yellow flags.
Where can I read the latest news about Tenaya Therapeutics, Inc.?
Recent headlines about Tenaya Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Tenaya Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Tenaya Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.